Purchase Order 75N94025P00575
- Not listed
- This is a $14,160 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH), to Cambridge Isotope Laboratories, Inc., a leading manufacturer and supplier of stable isotopes and isotope-labeled compounds. The award is for the provision of deuterium oxide to support ongoing biomedical research programs. Cambridge Isotope Laboratories, Inc., doing business as Cambridge Isotope Labs,...
- This contract award of $10,400.00 was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to the prime contractor Cambridge Isotope Laboratories, Inc. (doing business as Cambridge Isotope Labs). Cambridge Isotope Labs is a foreign-owned, for-profit manufacturer that specializes in producing stable isotopes and isotope-labeled compounds for biomedical research. The contract, which has...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), an institute within the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS), awarded a $16,520 purchase order to Cambridge Isotope Laboratories, Inc., doing business as Cambridge Isotope Labs, located in Tewksbury, Massachusetts. The contract calls for the delivery of deuterium oxide, also known as heavy water, to the NIDDK between September 18-30, 2023. Cambridge Isotope Labs...
- The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases awarded a firm fixed price purchase order valued at $86,400 to Cambridge Isotope Laboratories, Inc. for the delivery of 200 bottles of 99.9% deuterium oxide in one liter bottles. Cambridge Isotope Laboratories will deliver 100 bottles of deuterium oxide per shipment from its place of performance in St. Louis, Missouri to the NIH over the one year period of performance from September 2014 through...
- This is a $12,349.29 firm-fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Cambridge Isotope Laboratories, Inc. for the supply of 70% deuterium oxide. Cambridge Isotope Laboratories, Inc., a foreign-owned, for-profit manufacturer of specialized chemicals and materials, is a leading provider of stable isotopes and isotope-labeled compounds to federal...
- The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $24,850 firm fixed price purchase order to Cambridge Isotope Laboratories, Inc., doing business as Cambridge Isotope Labs, located in Tewksbury, Massachusetts. The contract is for the acquisition of 35 five-gram bottles of deuterium-labeled D-glucose (1,2,3,4,5,6,6D7, 9798%) to support the NIH-NIDDK's research programs. The period of performance is from August 23, 2023 through September...
- Cambridge Isotope Laboratories, Inc., doing business as Cambridge Isotope Labs, has been awarded a firm fixed-price purchase order valued at fifteen thousand one hundred sixty dollars by the National Institutes of Health's National Institute of Child Health and Human Development to supply deuterium oxide. The contract has a period of performance from August 2017 through August 2018 for the delivery of bottles containing 99.9% deuterium oxide to the agency's location in Andover, Massachusetts. No...
- This is a $80,000.00 firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, to Cambridge Isotope Laboratories, Inc. (doing business as Cambridge Isotope Labs). The contract is for the provision of stable isotopes and isotope-labeled compounds to support ongoing biomedical research programs at NIDA and other National Institutes of Health (NIH) institutes such as the National Institute of Diabetes and Digestive...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) awarded a $39,000 firm-fixed-price purchase order to Cambridge Isotope Laboratories, Inc. (CIL) for the delivery of deuterium oxide, D-glucose, glycerol, and other labeled compounds in support of biomedical research programs. CIL, a manufacturer of stable isotopes and isotopically labeled compounds, has provided similar labeled materials to NIH institutes like the...
- This federal contract award, with an ID of 75N94025P00252, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the National Institutes of Health (NIH). The $18,215.00 firm-fixed-price purchase order was awarded to Cambridge Isotope Laboratories, Inc., a foreign-owned, for-profit manufacturer of specialized isotopic compounds for scientific and medical research. The contract is for the delivery of a single batch of 1-13C palmitate...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a firm fixed-price purchase order to Cambridge Isotope Laboratories, Inc. for the procurement of deuterium oxide (D, 70%) to support metabolic research initiatives. The contract, valued at $14,788.00, was awarded on September 8, 2025, with an ultimate completion date of January 8, 2026. Cambridge Isotope Laboratories, a foreign-owned manufacturer headquartered in Andover, Massachusetts, specializes in producing stable isotopes and isotope-labeled compounds essential for biomedical research and pharmaceutical development. The work will be performed at the contractor's facility in Andover, MA. This procurement carries no set-aside designation, indicating the award was made through open competition. Cambridge Isotope Laboratories serves as a critical supplier of specialized isotopic materials to multiple NIH institutes and operates under a significant $10 million blanket purchase agreement with the NIH Office of Logistics and Acquisition Operations extending through January 2026. Deuterium oxide is a fundamental tracer compound utilized in metabolic studies to track biochemical processes and nutrient utilization in research applications. The contractor's extensive track record with NIDDK and other NIH institutes—including the National Institute of Mental Health, National Institute on Drug Abuse, and National Institute on Aging—demonstrates its established capability to deliver high-quality isotopically labeled compounds on schedule and within budget parameters for federally funded biomedical research programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.8k | 9/5/25 |